US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exelixis

36.19

+0.04000.11%

Post-market: 36.190.00000.00%19:12 EDT

Volume:2.26M

Turnover:81.71M

Market Cap:10.13B

PE:20.56

High:36.48

Open:36.03

Low:35.73

Close:36.15

Loading ...

Overview Company News Filings

Exelixis announces results from expansion cohort of phase 1b/2 STELLAR-001

Exelixis’s Cabozantinib Shows Promising Results for NET: Analyst Recommends ‘Buy’

Exelixis Announces Encouraging Results From Phase 1B/2 Stellar-001 Trial Evaluating Zanzalintinib Alone or in Combination With an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer at Asco Gi 2025

THOMSON REUTERS

Exelixis Reports Results on Drug Study to Treat Advanced Gastrointestinal Neuroendocrine Tumors

MT Newswires Live

Exelixis reports on subgroup analysis of Phase 3 CABINET study

Exelixis Shares Fall After Downgrade From Oppenheimer

MT Newswires Live

Exelixis Announces Results From Subgroup Analysis of Phase 3 Cabinet Pivotal Study Evaluating Cabozantinib in Advanced Gastrointestinal Neuroendocrine Tumors Presented at Asco Gi 2025

THOMSON REUTERS

Exelixis Stock Faces a Reality Check: Will It Hit $41 or Drop to $33?

Exelixis Stock Falls as Oppenheimer Downgrades Over Drug Differentiation Concerns

Exelixis : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS

Oppenheimer Downgrades Exelixis to Perform From Outperform, Adjusts Price Target to $33 From $41

MT Newswires Live

Exelixis Cut to Perform From Outperform by Oppenheimer

Exelixis Inc : Oppenheimer Cuts to Perform Rating; Cuts Target Price to $33 From $41

THOMSON REUTERS

Exelixis downgraded to Perform from Outperform at Oppenheimer

Exelixis downgraded to Perform at Oppenheimer on zanzalintinib concerns

Exelixis’ Promising Future: Zanzalintinib as a Successor to Cabozantinib

Exelixis Down Nearly 9%, On Pace for Largest Percent Decrease Since May 2022 -- Data Talk

Promising Outlook for Exelixis’s Zanza: Strong Trial Results and Financial Prospects Support Buy Rating

Jefferies has two ‘contradictory’ conclusions after Exelixis abstract release

Exelixis falls after ASCO releases colorectal cancer data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EXEL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":36.19,"timestamp":1744920000000,"preClose":36.15,"halted":0,"volume":2255385,"hourTrading":{"tag":"盘后","latestPrice":36.19,"preClose":36.19,"latestTime":"19:12 EDT","volume":46731,"amount":1691197.7417,"timestamp":1744931569983},"delay":0,"floatShares":235894721,"shares":279881450,"eps":1.76,"marketStatus":"Market Closed","change":0.04,"latestTime":"04-17 16:00:00 EDT","open":36.03,"high":36.48,"low":35.73,"amount":81711883.59295501,"amplitude":0.020747,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.76,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":36.15,"preHourTrading":{"tag":"盘前","latestPrice":36.07,"preClose":36.15,"latestTime":"09:29 EDT","volume":305,"amount":11038.000629999999,"timestamp":1744896569102},"postHourTrading":{"tag":"盘后","latestPrice":36.19,"preClose":36.19,"latestTime":"19:12 EDT","volume":46731,"amount":1691197.7417,"timestamp":1744931569983},"volumeRatio":0.959463878728634,"impliedVol":0.4421,"impliedVolPercentile":0.4382},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":235894721,"roa":"14.64%","roe":"23.13%","lyrEps":1.797286,"volumeRatio":0.959463878728634,"shares":279881450,"dividePrice":0,"high":36.48,"amplitude":0.020747,"preClose":36.15,"low":35.73,"week52Low":20.14,"pbRate":"4.51","psRate":"4.67","week52High":40.02,"institutionHeld":0.7772,"latestPrice":36.19,"eps":1.76,"divideRate":0,"volume":2255385,"delay":0,"ttmEps":1.76,"open":36.03,"prevYearClose":33.3,"prevWeekClose":35.31,"prevMonthClose":36.92,"prevQuarterClose":36.92,"fiveDayClose":34.46,"twentyDayClose":37.18,"sixtyDayClose":32.88},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506350299","title":"Exelixis announces results from expansion cohort of phase 1b/2 STELLAR-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2506350299","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506350299?lang=en_us&edition=fundamental","pubTime":"2025-01-26 22:35","pubTimestamp":1737902103,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) announced results from an expansion cohort of the phase 1b/2 STELLAR-001 trial evaluating zanzalintinib alone or in combination wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-announces-results-from-expansion-cohort-of-phase-1b-2-stellar-001?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-announces-results-from-expansion-cohort-of-phase-1b-2-stellar-001?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2506802563","title":"Exelixis’s Cabozantinib Shows Promising Results for NET: Analyst Recommends ‘Buy’","url":"https://stock-news.laohu8.com/highlight/detail?id=2506802563","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506802563?lang=en_us&edition=fundamental","pubTime":"2025-01-26 05:45","pubTimestamp":1737841523,"startTime":"0","endTime":"0","summary":"Analyst David Lebowitz from Citi maintained a Buy rating on Exelixis (EXEL – Research Report) and keeping the price target at $38.00. David Lebowit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/exelixiss-cabozantinib-shows-promising-results-for-net-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/exelixiss-cabozantinib-shows-promising-results-for-net-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4560","BK4585","BK4532","BK4548","EXEL","LU2286300806.USD","NET","BK4554","BK4139","BK4116"],"gpt_icon":0},{"id":"2506087111","title":"Exelixis Announces Encouraging Results From Phase 1B/2 Stellar-001 Trial Evaluating Zanzalintinib Alone or in Combination With an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer at Asco Gi 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506087111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506087111?lang=en_us&edition=fundamental","pubTime":"2025-01-25 23:00","pubTimestamp":1737817200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250125:nTUA8J40TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2506881886","title":"Exelixis Reports Results on Drug Study to Treat Advanced Gastrointestinal Neuroendocrine Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2506881886","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506881886?lang=en_us&edition=fundamental","pubTime":"2025-01-25 04:42","pubTimestamp":1737751359,"startTime":"0","endTime":"0","summary":"Exelixis  said a phase 3 study showed its cabozantinib drug reduced the risk of disease progression or death by 50% compared with placebo in patients with advanced gastrointestinal neuroendocrine tumorsThe study involved 116 patients with median progression-free survival of 8.5 months with cabozantinib compared with 5.6 months with placebo, the company said Friday in a statement.The results \"demonstrate the benefits of cabozantinib across a wide range of patients with neuroendocrine tumors and further underscore the potential of cabozantinib to become a much-needed new option,\" Exelixis Chief Medical Officer Amy Peterson said in the statement.The US Food and Drug Administration is currently reviewing a supplemental new drug application for cabozantinib, the company said.Shares of Exelixis fell 5.2% in late Friday trading. Earlier, Oppenheimer downgraded the stock to perform from outperform and cut the price target to $33 from $41.Price: 32.34, Change: -1.79, Percent Change: -5.24","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B66KJ199.SGD","AEIS","EXEL","BK6522","BK4139","BK4157","BK6088","IE00B7SZL793.SGD","IE0031619046.USD","IE00B19Z4B17.USD","BLZ.SI","BK4532"],"gpt_icon":0},{"id":"2506892476","title":"Exelixis reports on subgroup analysis of Phase 3 CABINET study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506892476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506892476?lang=en_us&edition=fundamental","pubTime":"2025-01-25 03:35","pubTimestamp":1737747326,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic neuroendocrine tu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-reports-on-subgroup-analysis-of-phase-3-cabinet-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-reports-on-subgroup-analysis-of-phase-3-cabinet-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2506689260","title":"Exelixis Shares Fall After Downgrade From Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2506689260","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506689260?lang=en_us&edition=fundamental","pubTime":"2025-01-25 03:32","pubTimestamp":1737747129,"startTime":"0","endTime":"0","summary":"Exelixis'  shares were down more than 6% in recent Friday trading after Oppenheimer downgraded the company's stock to perform from outperform, and adjusted its price target to $33 from $41.Trading volume stood at over 2.1 million shares against a daily average of about 2.3 million.Price: 31.99, Change: -2.14, Percent Change: -6.27","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL","OPY"],"gpt_icon":0},{"id":"2506989267","title":"Exelixis Announces Results From Subgroup Analysis of Phase 3 Cabinet Pivotal Study Evaluating Cabozantinib in Advanced Gastrointestinal Neuroendocrine Tumors Presented at Asco Gi 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506989267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506989267?lang=en_us&edition=fundamental","pubTime":"2025-01-25 03:30","pubTimestamp":1737747006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OK1MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2506894537","title":"Exelixis Stock Faces a Reality Check: Will It Hit $41 or Drop to $33?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894537","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506894537?lang=en_us&edition=fundamental","pubTime":"2025-01-25 02:37","pubTimestamp":1737743832,"startTime":"0","endTime":"0","summary":"Exelixis  just hit a speed bump. Oppenheimer downgraded the stock from Outperform to Perform, dialing back its price target to $33. The reason?Fresh data from ASCO-GI failed to prove that its next-gen cancer drug, zanzalintinib, has a meaningful edge over its blockbuster cabozantinib. That's a red flag for investors banking on the company's pipeline to fuel future growth. But let's not get ahead of ourselvesExelixis still boasts a rock-solid balance sheet, a 96% gross margin, and a stock that's climbed 39% in 2024, outpacing the Nasdaq Biotechnology Index. With cabozantinib sales jumping 11% year-over-year and new label expansions on the horizon, there's plenty to keep bulls interested.GuruFocus has detected 5 Warning Signs with EXEL.Wall Street is split. JMP Securities is sticking with its $41 target, betting on long-term pipeline success, while Oppenheimer is playing it safe at $33. To boost investor confidence, Exelixis is rolling out a $500 million share buybackalways a bullish sig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-stock-faces-reality-check-183712226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2506567860","title":"Exelixis Stock Falls as Oppenheimer Downgrades Over Drug Differentiation Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2506567860","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506567860?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:17","pubTimestamp":1737735436,"startTime":"0","endTime":"0","summary":"Exelixis  is down 5.95% to $32.10 as of 11:04 AM ET Friday, following a downgrade from Oppenheimer, which cut its rating to Perform from Outperform due to concerns over drug differentiation. The firm pointed to uncertainty between Exelixis' cancer therapies, zanzalintinib and cabozantinib, after reviewing an abstract from the STELLAR-001 study presented at the ASCO GI medical meeting.GuruFocus has detected 5 Warning Signs with EXEL.While Oppenheimer noted that the data may help de-risk the Phase 3 STELLAR-303 trial in metastatic colorectal cancer , analysts do not yet see clear differentiation for zanzalintinib. With this lack of clarity, Oppenheimer is taking a cautious stance, choosing to stay on the sidelines until more data emerges. As a result, the firm lowered its price target from $41 to $33, reflecting a more neutral outlook on the stock. This article first appeared on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-stock-falls-oppenheimer-downgrades-161716952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OPY","EXEL"],"gpt_icon":0},{"id":"2505222857","title":"Exelixis : Oppenheimer Cuts to Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2505222857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505222857?lang=en_us&edition=fundamental","pubTime":"2025-01-24 21:27","pubTimestamp":1737725231,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nAZN377M7J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0},{"id":"2505573448","title":"Oppenheimer Downgrades Exelixis to Perform From Outperform, Adjusts Price Target to $33 From $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2505573448","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505573448?lang=en_us&edition=fundamental","pubTime":"2025-01-24 21:13","pubTimestamp":1737724415,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $35.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL","OPY"],"gpt_icon":0},{"id":"2505511398","title":"Exelixis Cut to Perform From Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505511398","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505511398?lang=en_us&edition=fundamental","pubTime":"2025-01-24 20:31","pubTimestamp":1737721860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 24, 2025 07:31 ET (12:31 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","OPY"],"gpt_icon":0},{"id":"2505007809","title":"Exelixis Inc : Oppenheimer Cuts to Perform Rating; Cuts Target Price to $33 From $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2505007809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505007809?lang=en_us&edition=fundamental","pubTime":"2025-01-24 13:15","pubTimestamp":1737695729,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OJ224:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2505002935","title":"Exelixis downgraded to Perform from Outperform at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505002935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505002935?lang=en_us&edition=fundamental","pubTime":"2025-01-24 05:16","pubTimestamp":1737666968,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Jay Olson downgraded Exelixis (EXEL) to Perform from Outperform. Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-downgraded-to-perform-from-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-downgraded-to-perform-from-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","EXEL"],"gpt_icon":0},{"id":"2505102938","title":"Exelixis downgraded to Perform at Oppenheimer on zanzalintinib concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2505102938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505102938?lang=en_us&edition=fundamental","pubTime":"2025-01-24 05:15","pubTimestamp":1737666913,"startTime":"0","endTime":"0","summary":"As previously reported, Oppenheimer downgraded Exelixis (EXEL) to Perform from Outperform with a price target of $33, down from $41. The firm is co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-downgraded-to-perform-at-oppenheimer-on-zanzalintinib-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-downgraded-to-perform-at-oppenheimer-on-zanzalintinib-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","OPY"],"gpt_icon":0},{"id":"2505905807","title":"Exelixis’ Promising Future: Zanzalintinib as a Successor to Cabozantinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2505905807","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505905807?lang=en_us&edition=fundamental","pubTime":"2025-01-23 13:35","pubTimestamp":1737610534,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Silvan Tuerkcan has maintained their bullish stance on EXEL stock, giving a Buy rating yesterday. Silvan Tuerkcan’s rating i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/exelixis-promising-future-zanzalintinib-as-a-successor-to-cabozantinib?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/exelixis-promising-future-zanzalintinib-as-a-successor-to-cabozantinib?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2505770041","title":"Exelixis Down Nearly 9%, On Pace for Largest Percent Decrease Since May 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2505770041","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505770041?lang=en_us&edition=fundamental","pubTime":"2025-01-23 03:55","pubTimestamp":1737575700,"startTime":"0","endTime":"0","summary":"Exelixis, Inc.  is currently at $33.17, down $3.26 or 8.95%. --Would be lowest close since Oct. 30, 2024, when it closed at $32.44. --On pace for largest percent decrease since May 19, 2022, when it fell 10.52%. --Down 32.65% from its all-time closing high of $49.25 on July 26, 2000. --Up 50.02% from 52 weeks ago , when it closed at $22.11. --Down 11% from its 52-week closing high of $37.27 on Jan. 15, 2025. --Traded as low as $32.73; lowest intraday level since Oct. 31, 2024, when it hit $32.30. --Down 10.16% at today's intraday low; largest intraday percent decrease since May 1, 2024, when it fell as much as 11.81%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2505677132","title":"Promising Outlook for Exelixis’s Zanza: Strong Trial Results and Financial Prospects Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2505677132","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505677132?lang=en_us&edition=fundamental","pubTime":"2025-01-23 01:55","pubTimestamp":1737568542,"startTime":"0","endTime":"0","summary":"Jefferies analyst Akash Tewari maintained a Buy rating on Exelixis (EXEL – Research Report) today and set a price target of $42.00. Akash Tewari’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-exelixiss-zanza-strong-trial-results-and-financial-prospects-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-exelixiss-zanza-strong-trial-results-and-financial-prospects-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2505771310","title":"Jefferies has two ‘contradictory’ conclusions after Exelixis abstract release","url":"https://stock-news.laohu8.com/highlight/detail?id=2505771310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505771310?lang=en_us&edition=fundamental","pubTime":"2025-01-23 01:55","pubTimestamp":1737568508,"startTime":"0","endTime":"0","summary":"After the American Society of Clinical Oncology released an abstract on data for zanzalintinib alone or in combination with atezolizumab in patient...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-has-two-contradictory-conclusions-after-exelixis-abstract-release?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-has-two-contradictory-conclusions-after-exelixis-abstract-release?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2505549776","title":"Exelixis falls after ASCO releases colorectal cancer data","url":"https://stock-news.laohu8.com/highlight/detail?id=2505549776","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505549776?lang=en_us&edition=fundamental","pubTime":"2025-01-23 01:20","pubTimestamp":1737566410,"startTime":"0","endTime":"0","summary":"Shares of Exelixis (EXEL) are moving lower after the American Society of Clinical Oncology released an abstract on data for zanzalintinib alone or ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-falls-after-asco-releases-colorectal-cancer-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-falls-after-asco-releases-colorectal-cancer-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-11","symbol":"EXEL","fiscalQuarterEnding":"2024/12","expectedEps":0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2025-01-12","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-29","symbol":"EXEL","fiscalQuarterEnding":"2024/09","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"post","actualEps":0.4},{"market":"US","date":"2024-08-06","symbol":"EXEL","fiscalQuarterEnding":"2024/06","expectedEps":0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":0.75},{"market":"US","date":"2024-04-30","symbol":"EXEL","fiscalQuarterEnding":"2024/03","expectedEps":0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714449600000,"reportTimeType":"post","actualEps":0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.35,"hold":0.45,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.35,"analysts":20,"updateTime":1740456000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2025-04-17","current":19.40985,"percent":0.093596,"low":16.158427,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"high":123.671097,"avg":38.32699,"sd":22.11075,"marketCap":10117714417},"quantilePoints":[{"date":"2020-04-24","current":25.26731,"twenty":-27.325861,"median":-2.675639,"eighty":15.998656,"marketCap":8111109648},{"date":"2020-05-01","current":22.952965,"twenty":-27.325861,"median":-2.655085,"eighty":16.258055,"marketCap":7368177253},{"date":"2020-05-08","current":27.133421,"twenty":-27.325861,"median":-2.655085,"eighty":16.384068,"marketCap":7973128644},{"date":"2020-05-15","current":26.882959,"twenty":-27.325861,"median":-2.655085,"eighty":16.477819,"marketCap":7899530533},{"date":"2020-05-22","current":25.693263,"twenty":-27.325861,"median":-2.655085,"eighty":16.669769,"marketCap":7549939508},{"date":"2020-05-29","current":25.787186,"twenty":-27.325861,"median":-2.655085,"eighty":16.772736,"marketCap":7577538799},{"date":"2020-06-05","current":23.345178,"twenty":-27.325861,"median":-2.655085,"eighty":16.914711,"marketCap":6859957221},{"date":"2020-06-12","current":23.36605,"twenty":-27.325861,"median":-2.655085,"eighty":17.072198,"marketCap":6866090397},{"date":"2020-06-19","current":25.234082,"twenty":-27.325861,"median":-2.655085,"eighty":17.193665,"marketCap":7415009638},{"date":"2020-06-26","current":23.877411,"twenty":-27.325861,"median":-2.498063,"eighty":17.327033,"marketCap":7016353206},{"date":"2020-07-02","current":24.503566,"twenty":-27.325861,"median":2.570279,"eighty":17.449214,"marketCap":7200348483},{"date":"2020-07-10","current":26.027212,"twenty":-27.325861,"median":7.700066,"eighty":17.686188,"marketCap":7648070322},{"date":"2020-07-17","current":25.672391,"twenty":-27.325861,"median":7.798866,"eighty":17.752451,"marketCap":7543806332},{"date":"2020-07-24","current":25.661955,"twenty":-27.325861,"median":7.918086,"eighty":17.906096,"marketCap":7540739744},{"date":"2020-07-31","current":24.096565,"twenty":-27.325861,"median":7.952297,"eighty":18.137028,"marketCap":7080751553},{"date":"2020-08-07","current":24.532882,"twenty":-27.325861,"median":8.048191,"eighty":18.372123,"marketCap":6909146512},{"date":"2020-08-14","current":24.115955,"twenty":-27.325861,"median":8.142361,"eighty":18.523046,"marketCap":6791728101},{"date":"2020-08-21","current":24.412193,"twenty":-27.325861,"median":8.236764,"eighty":18.814893,"marketCap":6875156972},{"date":"2020-08-28","current":23.731943,"twenty":-27.325861,"median":8.306231,"eighty":18.921262,"marketCap":6683579564},{"date":"2020-09-04","current":22.678653,"twenty":-27.325861,"median":8.452997,"eighty":19.15433,"marketCap":6386943578},{"date":"2020-09-11","current":23.84166,"twenty":-27.325861,"median":8.522074,"eighty":19.393808,"marketCap":6714479146},{"date":"2020-09-18","current":29.404349,"twenty":-27.325861,"median":8.639223,"eighty":21.878582,"marketCap":8281087949},{"date":"2020-09-25","current":26.156704,"twenty":-27.325861,"median":8.733376,"eighty":22.567702,"marketCap":7366460324},{"date":"2020-10-02","current":25.673946,"twenty":-27.325861,"median":8.760246,"eighty":22.741605,"marketCap":7230502164},{"date":"2020-10-09","current":26.233507,"twenty":-27.325861,"median":8.79746,"eighty":22.926619,"marketCap":7388090032},{"date":"2020-10-16","current":25.487426,"twenty":-27.325861,"median":8.876649,"eighty":23.321013,"marketCap":7177972875},{"date":"2020-10-23","current":24.45608,"twenty":-27.325861,"median":8.972487,"eighty":23.456447,"marketCap":6887516805},{"date":"2020-10-30","current":22.470189,"twenty":-27.325861,"median":8.98742,"eighty":23.487127,"marketCap":6328234373},{"date":"2020-11-06","current":42.232952,"twenty":-27.325861,"median":9.087264,"eighty":23.557982,"marketCap":6425152432},{"date":"2020-11-13","current":41.111363,"twenty":-27.325861,"median":9.098481,"eighty":23.685842,"marketCap":6254518253},{"date":"2020-11-20","current":38.562295,"twenty":-27.325861,"median":9.113834,"eighty":23.779449,"marketCap":5866713302},{"date":"2020-11-27","current":39.581922,"twenty":-27.325861,"median":9.129175,"eighty":23.84411,"marketCap":6021835283},{"date":"2020-12-04","current":38.705043,"twenty":-27.325861,"median":9.164612,"eighty":23.920269,"marketCap":5888430379},{"date":"2020-12-11","current":40.519979,"twenty":-27.325861,"median":9.190147,"eighty":24.042286,"marketCap":6164547505},{"date":"2020-12-18","current":40.683119,"twenty":-27.325861,"median":9.209534,"eighty":24.112523,"marketCap":6189367021},{"date":"2020-12-24","current":42.232952,"twenty":-27.325861,"median":9.239511,"eighty":24.160872,"marketCap":6425152432},{"date":"2020-12-31","current":40.92783,"twenty":-27.325861,"median":9.247119,"eighty":24.259288,"marketCap":6226596297},{"date":"2021-01-08","current":46.535778,"twenty":-27.325861,"median":9.290936,"eighty":24.393046,"marketCap":7079767190},{"date":"2021-01-15","current":48.381303,"twenty":-27.325861,"median":9.331472,"eighty":24.439962,"marketCap":7360537974},{"date":"2021-01-22","current":45.149086,"twenty":-27.325861,"median":9.352389,"eighty":24.47852,"marketCap":6868801296},{"date":"2021-01-29","current":45.291833,"twenty":-27.325861,"median":9.385679,"eighty":24.575729,"marketCap":6890518373},{"date":"2021-02-05","current":47.249517,"twenty":-27.325861,"median":9.422035,"eighty":24.692782,"marketCap":7188352576},{"date":"2021-02-12","current":61.152553,"twenty":-27.325861,"median":9.475859,"eighty":24.765611,"marketCap":6835693472},{"date":"2021-02-19","current":61.989876,"twenty":-27.325861,"median":9.52696,"eighty":24.818203,"marketCap":6929290370},{"date":"2021-02-26","current":60.454783,"twenty":-27.325861,"median":9.582451,"eighty":24.859848,"marketCap":6757696057},{"date":"2021-03-05","current":62.324806,"twenty":-27.329077,"median":9.628878,"eighty":24.949115,"marketCap":6966729130},{"date":"2021-03-12","current":64.976331,"twenty":-27.329077,"median":9.656734,"eighty":25.006772,"marketCap":7263119308},{"date":"2021-03-19","current":65.311261,"twenty":-27.329077,"median":9.710451,"eighty":25.161223,"marketCap":7300558067},{"date":"2021-03-26","current":63.329595,"twenty":-27.325861,"median":9.736947,"eighty":25.234082,"marketCap":7079045408},{"date":"2021-04-01","current":64.529759,"twenty":-27.325861,"median":9.747742,"eighty":25.270502,"marketCap":7213200962},{"date":"2021-04-09","current":64.529759,"twenty":-27.329077,"median":9.805299,"eighty":25.357929,"marketCap":7213200962},{"date":"2021-04-16","current":66.075436,"twenty":-27.329077,"median":9.834498,"eighty":25.412148,"marketCap":7385978281},{"date":"2021-04-23","current":69.268568,"twenty":-27.329077,"median":9.92067,"eighty":25.491815,"marketCap":7742909830},{"date":"2021-04-30","current":68.960459,"twenty":-27.329077,"median":9.944579,"eighty":25.677015,"marketCap":7708469067},{"date":"2021-05-07","current":121.493789,"twenty":-27.329077,"median":9.977077,"eighty":25.790166,"marketCap":7869152717},{"date":"2021-05-14","current":123.671097,"twenty":-27.329077,"median":10.042797,"eighty":25.900353,"marketCap":8010176959},{"date":"2021-05-21","current":118.348789,"twenty":-27.329077,"median":10.090291,"eighty":26.029567,"marketCap":7665451034},{"date":"2021-05-28","current":109.107325,"twenty":-27.329077,"median":10.142137,"eighty":26.116578,"marketCap":7066881472},{"date":"2021-06-04","current":108.236402,"twenty":-27.329077,"median":10.259913,"eighty":26.305665,"marketCap":7010471775},{"date":"2021-06-11","current":111.187864,"twenty":-27.329077,"median":10.30588,"eighty":26.528137,"marketCap":7201637970},{"date":"2021-06-18","current":108.429941,"twenty":-27.329077,"median":10.499122,"eighty":26.899667,"marketCap":7023007264},{"date":"2021-06-25","current":113.316788,"twenty":-27.329077,"median":10.577409,"eighty":27.427848,"marketCap":7339528341},{"date":"2021-07-02","current":88.350322,"twenty":-27.329077,"median":10.668743,"eighty":28.437015,"marketCap":5722450363},{"date":"2021-07-09","current":87.140707,"twenty":-27.329077,"median":10.768777,"eighty":32.735526,"marketCap":5644103562},{"date":"2021-07-16","current":81.286167,"twenty":-27.329077,"median":12.586346,"eighty":38.333898,"marketCap":5264905044},{"date":"2021-07-23","current":80.947475,"twenty":-27.329077,"median":13.259462,"eighty":38.843712,"marketCap":5242967939},{"date":"2021-07-30","current":81.52809,"twenty":-27.329077,"median":13.665176,"eighty":39.250255,"marketCap":5280574404},{"date":"2021-08-06","current":57.789598,"twenty":-27.329077,"median":14.041856,"eighty":39.491398,"marketCap":5434591593},{"date":"2021-08-13","current":61.240223,"twenty":-27.329077,"median":14.246084,"eighty":40.05544,"marketCap":5759091844},{"date":"2021-08-20","current":61.776243,"twenty":-27.329077,"median":14.431907,"eighty":40.44398,"marketCap":5809499650},{"date":"2021-08-27","current":65.092863,"twenty":-27.329077,"median":14.633356,"eighty":40.76874,"marketCap":6121397950},{"date":"2021-09-03","current":66.231905,"twenty":-27.329077,"median":14.930088,"eighty":41.024831,"marketCap":6228514538},{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":29.519358,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6053062389},{"date":"2024-06-07","current":31.50815,"twenty":17.668364,"median":30.926871,"eighty":50.389968,"marketCap":6460872174},{"date":"2024-06-14","current":31.195625,"twenty":17.731278,"median":31.024392,"eighty":50.736642,"marketCap":6396787779},{"date":"2024-06-21","current":30.868895,"twenty":17.766317,"median":31.025137,"eighty":51.083315,"marketCap":6329790457},{"date":"2024-06-28","current":32.005348,"twenty":17.852912,"median":31.063965,"eighty":53.63882,"marketCap":6562824621},{"date":"2024-07-05","current":31.195625,"twenty":17.982935,"median":31.110391,"eighty":53.63882,"marketCap":6396787779},{"date":"2024-07-12","current":32.033759,"twenty":18.146511,"median":31.178387,"eighty":53.63882,"marketCap":6568650475},{"date":"2024-07-15","current":31.820674,"twenty":18.176822,"median":31.195625,"eighty":53.63882,"marketCap":6524956569},{"date":"2024-08-02","current":34.406104,"twenty":18.456098,"median":31.288944,"eighty":57.789598,"marketCap":7055109290},{"date":"2024-08-09","current":22.14419,"twenty":18.510802,"median":31.323476,"eighty":57.789598,"marketCap":7750289368},{"date":"2024-08-16","current":21.44327,"twenty":18.768662,"median":31.323476,"eighty":57.789598,"marketCap":7504972884},{"date":"2024-08-23","current":21.011307,"twenty":18.973137,"median":31.323476,"eighty":57.789598,"marketCap":7353789470},{"date":"2024-08-30","current":21.206913,"twenty":19.112302,"median":31.323476,"eighty":57.789598,"marketCap":7422249884},{"date":"2024-09-06","current":20.840152,"twenty":19.183708,"median":31.323476,"eighty":57.789598,"marketCap":7293886608},{"date":"2024-09-13","current":21.44327,"twenty":19.289956,"median":31.323476,"eighty":57.789598,"marketCap":7504972884},{"date":"2024-09-20","current":21.867082,"twenty":19.478842,"median":31.323476,"eighty":57.789598,"marketCap":7653303781},{"date":"2024-09-27","current":21.386218,"twenty":19.575801,"median":31.323476,"eighty":57.789598,"marketCap":7485005264},{"date":"2024-10-04","current":21.386218,"twenty":19.877132,"median":31.323476,"eighty":57.789598,"marketCap":7485005264},{"date":"2024-10-11","current":20.954256,"twenty":20.21075,"median":31.323476,"eighty":57.789598,"marketCap":7333821849},{"date":"2024-10-18","current":23.684585,"twenty":20.318368,"median":31.323476,"eighty":57.789598,"marketCap":8289415128},{"date":"2024-10-25","current":22.910312,"twenty":20.693448,"median":31.323476,"eighty":57.789598,"marketCap":8018425989},{"date":"2024-10-31","current":19.840881,"twenty":20.791251,"median":31.323476,"eighty":57.789598,"marketCap":9264183408},{"date":"2024-11-08","current":21.895917,"twenty":20.951195,"median":31.330579,"eighty":57.923603,"marketCap":10223728916},{"date":"2024-11-15","current":21.437203,"twenty":20.974348,"median":31.330579,"eighty":57.923603,"marketCap":10009544651},{"date":"2024-11-22","current":21.302647,"twenty":21.045396,"median":31.330579,"eighty":57.923603,"marketCap":9946717266},{"date":"2024-11-29","current":22.299584,"twenty":21.095503,"median":31.330579,"eighty":57.923603,"marketCap":10412211069},{"date":"2024-12-06","current":22.042705,"twenty":21.156382,"median":31.330579,"eighty":57.923603,"marketCap":10292267880},{"date":"2024-12-13","current":21.516713,"twenty":21.234624,"median":31.330579,"eighty":57.923603,"marketCap":10046669923},{"date":"2024-12-20","current":20.599287,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9618301393},{"date":"2024-12-27","current":20.813353,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9718254050},{"date":"2025-01-03","current":20.758307,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9692551938},{"date":"2025-01-10","current":21.100813,"twenty":21.272083,"median":31.337682,"eighty":58.057608,"marketCap":9852476190},{"date":"2025-01-17","current":22.35463,"twenty":21.382958,"median":31.337682,"eighty":58.057608,"marketCap":10437913181},{"date":"2025-01-24","current":20.874515,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9746811952},{"date":"2025-01-31","current":20.140573,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9404117128},{"date":"2025-02-07","current":20.593171,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9615445603},{"date":"2025-02-14","current":18.518554,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9653111210},{"date":"2025-02-21","current":18.840709,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9821040080},{"date":"2025-02-28","current":20.215238,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":10537536592},{"date":"2025-03-07","current":20.515916,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10694270204},{"date":"2025-03-14","current":19.758852,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10299637360},{"date":"2025-03-21","current":19.962883,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10405992311},{"date":"2025-03-28","current":19.780329,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10310832618},{"date":"2025-04-04","current":19.694421,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10266051586},{"date":"2025-04-11","current":18.502446,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9644714767},{"date":"2025-04-17","current":19.40985,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":10117714417}],"updateTime":1745134336966}}}